Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 1999. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme
- PMID: 11089306
- DOI: 10.33321/cdi.2000.24.46
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 1999. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme
Abstract
A long-term programme of surveillance of antimicrobial resistance in Neisseria gonorrhoeae isolated in the World Health Organization's Western Pacific Region Gonococcal Antimicrobial Surveillance Programme ((WHO WPR GASP) continued in 1999. Over 10,000 gonococci were examined in 18 focal centres. Resistance to the quinolones and penicillins was already high in many parts of the Western Pacific Region and increased further in most centres, the exceptions being a number of Pacific Island States. Although resistance to the later generation cephalosporins was absent, and that to spectinomycin infrequent, options for effective treatment of gonorrhoea in the Western Pacific Region continue to be limited.
Similar articles
-
Resistance in gonococci isolated in the WHO Western Pacific Region to various antimicrobials used in the treatment of gonorrhoea, 1997. WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme-WHO WPR GASP.Commun Dis Intell. 1998 Dec 24;22(13):288-91. doi: 10.33321/cdi.1998.22.62. Commun Dis Intell. 1998. PMID: 9893340
-
Antimicrobial resistance in gonococci, WHO Western Pacific Region, 1996. The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme.Commun Dis Intell. 1997 Dec 25;21(23):349-53. doi: 10.33321/cdi.1997.21.60. Commun Dis Intell. 1997. PMID: 9444789
-
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 1998. The WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme.Commun Dis Intell. 2000 Jan 20;24(1):1-4. doi: 10.33321/cdi.2000.24.1. Commun Dis Intell. 2000. PMID: 10734698
-
Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016.PLoS One. 2019 Apr 3;14(4):e0213312. doi: 10.1371/journal.pone.0213312. eCollection 2019. PLoS One. 2019. PMID: 30943199 Free PMC article.
-
Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union.Sex Transm Infect. 2013 Dec;89 Suppl 4:iv42-6. doi: 10.1136/sextrans-2012-050909. Sex Transm Infect. 2013. PMID: 24243879 Review.
Cited by
-
Safety Aspects and Rational Use of Single Intramuscular Dose Ceftriaxone: Clinical Insights on the Management of Uncomplicated Gonococcal Infections.Drug Healthc Patient Saf. 2023 Nov 3;15:159-170. doi: 10.2147/DHPS.S350763. eCollection 2023. Drug Healthc Patient Saf. 2023. PMID: 37941731 Free PMC article. Review.
-
The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds.J Bacteriol. 2003 Feb;185(3):1101-6. doi: 10.1128/JB.185.3.1101-1106.2003. J Bacteriol. 2003. PMID: 12533487 Free PMC article.
-
The Prevalence of Antimicrobial Resistant Neisseria gonorrhoeae in Papua New Guinea: A Systematic Review and Meta-Analysis.Int J Environ Res Public Health. 2022 Jan 28;19(3):1520. doi: 10.3390/ijerph19031520. Int J Environ Res Public Health. 2022. PMID: 35162547 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical